Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Cervical Cancer

  Free Subscription


1 BMC Health Serv Res
1 BMJ Case Rep
2 Br J Cancer
1 Br J Radiol
1 CA Cancer J Clin
1 Cancer Cell Int
1 Diagn Cytopathol
1 Drug Des Devel Ther
1 Gynecol Oncol
2 Int J Cancer
5 Int J Gynaecol Obstet
1 J Cancer Res Ther
1 J Environ Public Health
1 J Microbiol Biotechnol
1 J Virol
1 Lancet Infect Dis
1 Obstet Gynecol
2 Oncol Lett
3 Oncotarget
1 PLoS One
1 Prev Med
1 Public Health Genomics
1 Updates Surg

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    BMC Health Serv Res

  1. VAN MINH H, My NTT, Jit M
    Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study.
    BMC Health Serv Res. 2017;17:353.
    PubMed     Text format     Abstract available

    BMJ Case Rep

  2. ARORA A, Rastogi A, Neyaz A, Husain N, et al
    Clear cell adenocarcinoma of cervix in 1-year-old girl without in utero exposure to diethylstilbestrol: an uncommon tumour at an uncommon age and site.
    BMJ Case Rep. 2017;2017.
    PubMed     Text format     Abstract available

    Br J Cancer

  3. SOGAARD M, Farkas DK, Ording AG, Sorensen HT, et al
    Conisation as a marker of persistent human papilloma virus infection and risk of breast cancer.
    Br J Cancer. 2016 Jun 2. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available

  4. LUTTMER R, De Strooper LM, Dijkstra MG, Berkhof J, et al
    FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.
    Br J Cancer. 2016 Jul 14. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available

    Br J Radiol

  5. UENO Y, Lisbona R, Tamada T, Alaref A, et al
    Comparison of FDG PET Metabolic Tumour Volume versus ADC Histogram: Prognostic Value of Tumour Treatment Response and Survival in Patients with Locally Advanced Uterine Cervical Cancer.
    Br J Radiol. 2017 May 16:20170035. doi: 10.1259/bjr.20170035.
    PubMed     Text format     Abstract available

    CA Cancer J Clin

  6. SMITH RA, Andrews KS, Brooks D, Fedewa SA, et al
    Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening.
    CA Cancer J Clin. 2017;67:100-121.
    PubMed     Text format     Abstract available

    Cancer Cell Int

  7. XU F, Zhang J, Hu G, Liu L, et al
    Hypoxia and TGF-beta1 induced PLOD2 expression improve the migration and invasion of cervical cancer cells by promoting epithelial-to-mesenchymal transition (EMT) and focal adhesion formation.
    Cancer Cell Int. 2017;17:54.
    PubMed     Text format     Abstract available

    Diagn Cytopathol

  8. PAGANO A, Dennis K
    Cribriform adenocarcinoma of the minor salivary gland arising in the tonsil with metastasis to a cervical lymph node: A case report with description of fine needle aspiration cytology.
    Diagn Cytopathol. 2017;45:468-471.
    PubMed     Text format     Abstract available

    Drug Des Devel Ther

    Spotlight on the 9-valent HPV vaccine.
    Drug Des Devel Ther. 2016;11:35-44.
    PubMed     Text format     Abstract available

    Gynecol Oncol

  10. WOLF B, Ganzer R, Stolzenburg JU, Hentschel B, et al
    Extended mesometrial resection (EMMR): Surgical approach to the treatment of locally advanced cervical cancer based on the theory of ontogenetic cancer fields.
    Gynecol Oncol. 2017 May 16. pii: S0090-8258(17)30845.
    PubMed     Text format     Abstract available

    Int J Cancer

  11. MATSUO K, Shimada M, Aoki Y, Sakamoto M, et al
    Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation.
    Int J Cancer. 2017 May 19. doi: 10.1002/ijc.30793.
    PubMed     Text format     Abstract available

  12. KOCSIS A, Takacs T, Jeney C, Schaff Z, et al
    Performance of a New HPV and Biomarker Assay in Management of hrHPV Positive Women: Subanalysis of the Ongoing Multicenter TRACE Clinical Trial (n>6,000) to Evaluate POU4F3 as a Potential Biomarker of Cervical Precancer and Cancer.
    Int J Cancer. 2016 Nov 22. doi: 10.1002/ijc.30534.
    PubMed     Text format     Abstract available

    Int J Gynaecol Obstet

  13. MARIANI L, Preti M, Cristoforoni P, Stigliano CM, et al
    Overview of the benefits and potential issues of the nonavalent HPV vaccine.
    Int J Gynaecol Obstet. 2016 Dec 7. doi: 10.1002/ijgo.12075.
    PubMed     Text format     Abstract available

  14. MARIANI L, Igidbashian S, Sandri MT, Vici P, et al
    The clinical implementation of primary HPV screening.
    Int J Gynaecol Obstet. 2016 Nov 21. doi: 10.1002/ijgo.12065.
    PubMed     Text format     Abstract available

  15. FAJARDO-RAMIREZ OR, Barboza-Cerda MC, Ortiz-Lopez R, Rojas-Martinez A, et al
    Prevalence and 3-year persistence of human papillomavirus serotypes in asymptomatic patients in Northern Mexico.
    Int J Gynaecol Obstet. 2017;136:40-46.
    PubMed     Text format     Abstract available

  16. FIGUEROA-DOWNING D, Baggio ML, Baker ML, Dias De Oliveira Chiang E, et al
    Factors influencing HPV vaccine delivery by healthcare professionals at public health posts in Sao Paulo, Brazil.
    Int J Gynaecol Obstet. 2017;136:33-39.
    PubMed     Text format     Abstract available

  17. ZHANG G, Lang J, Shen K, Zhu L, et al
    High-risk human papillomavirus infection clearance following conization among patients with cervical intraepithelial neoplasm grade 3 aged at least 45 years.
    Int J Gynaecol Obstet. 2017;136:47-52.
    PubMed     Text format     Abstract available

    J Cancer Res Ther

  18. PATNI N, Burela N, Pasricha R, Goyal J, et al
    Assessment of three-dimensional setup errors in image-guided pelvic radiotherapy for uterine and cervical cancer using kilovoltage cone-beam computed tomography and its effect on planning target volume margins.
    J Cancer Res Ther. 2017;13:131-136.
    PubMed     Text format     Abstract available

    J Environ Public Health

  19. DE ALMEIDA LM, Martins LFL, Pontes VB, Correa FM, et al
    Human Papillomavirus Genotype Distribution among Cervical Cancer Patients prior to Brazilian National HPV Immunization Program.
    J Environ Public Health. 2017;2017:1645074.
    PubMed     Text format     Abstract available

    J Microbiol Biotechnol

  20. PARK CW, Song YS, Lee HP, Hong JT, et al
    (E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol induces apoptosis in HeLa cervical cancer cells via the extrinsic apoptotic pathway.
    J Microbiol Biotechnol. 2017 May 17. doi: 10.4014/jmb.1703.03060.
    PubMed     Text format     Abstract available

    J Virol

  21. SZALMAS A, Tomaic V, Basukala O, Massimi P, et al
    The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available

    Lancet Infect Dis

  22. WHEELER CM, Skinner SR, Del Rosario-Raymundo MR, Garland SM, et al
    Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
    Lancet Infect Dis. 2016 Jun 28. pii: S1473-3099(16)30120.
    PubMed     Text format     Abstract available

    Obstet Gynecol

  23. SMELTZER S, Yu X, Schmeler K, Levison J, et al
    Abnormal Vaginal Pap Test After Hysterectomy in Human Immunodeficiency Virus-Infected Women.
    Obstet Gynecol. 2016;127.
    PubMed     Text format     Abstract available

    Oncol Lett

  24. BRONOWICKA-KLYS DE, Roszak A, Pawlik P, Sajdak S, et al
    Transcript levels of ten-eleven translocation type 1-3 in cervical cancer and non-cancerous cervical tissues.
    Oncol Lett. 2017;13:3921-3927.
    PubMed     Text format     Abstract available

  25. TONG R, Yang Q, Wang C, Bi F, et al
    OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia.
    Oncol Lett. 2017;13:2929-2936.
    PubMed     Text format     Abstract available


  26. LI Y, Cui N, Zheng PS, Yang WT, et al
    BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways.
    Oncotarget. 2017 Apr 27. doi: 10.18632/oncotarget.17493.
    PubMed     Text format     Abstract available

  27. LIN M, Xue X, Liang SZ, Li YX, et al
    MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6.
    Oncotarget. 2017 Apr 29. doi: 10.18632/oncotarget.17516.
    PubMed     Text format     Abstract available

  28. CUI X, Jing X, Wu X
    The prognostic value of long non coding RNAs in cervical cancer: A meta-analysis.
    Oncotarget. 2017 May 4. doi: 10.18632/oncotarget.17620.
    PubMed     Text format     Abstract available

    PLoS One

  29. MCKAY J, Tenet V, Franceschi S, Chabrier A, et al
    Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control study.
    PLoS One. 2017;12:e0177775.
    PubMed     Text format     Abstract available

    Prev Med

  30. WATSON M, Benard V, King J, Crawford A, et al
    National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey.
    Prev Med. 2017 May 11. pii: S0091-7435(17)30168.
    PubMed     Text format     Abstract available

    Public Health Genomics

  31. KABEKKODU SP, Chakrabarty S, Ghosh S, Brand A, et al
    Epigenomics, Pharmacoepigenomics, and Personalized Medicine in Cervical Cancer.
    Public Health Genomics. 2017 May 19. doi: 10.1159/000475804.
    PubMed     Text format     Abstract available

    Updates Surg

  32. PELLEGRINO A, Damiani GR, Fachechi G, Pirovano C, et al
    Cost analysis of minimally invasive radical hysterectomy for cervical cancer performed by a single surgeon in an Italian center: an update in gynecologic oncological field.
    Updates Surg. 2017 May 15. doi: 10.1007/s13304-017-0462.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.